Posted on 11/11/2009 in Pharmacy / Pharmacist News Kimberly-Clark has published its financial results for the third quarter of 2009, reporting a decrease in net sales of 1.7 per cent to $4.9 billion (2.9 billion pounds).
This, it states is due to the effect of weaker foreign currency exchange rates.
A growth in organic sales was driven by higher net selling prices and the firm revealed that overall, these volumes were even with those recorded during the same period of 2008.
Sales increased by around 18 per cent for Kimberly-Clark's global healthcare business and about three per cent for its operations in developing and emerging markets.
"All-in-all, we continue to execute our business plans well and I'm really pleased that bottom-line results in the third quarter are spurring a significant increase in our outlook for the year," explained chairman and chief executive officer Thomas Falk.
At the beginning of September, Kimberly-Clark announced that it had recruited Kim Underhill as its new vice-president, following the departure of former employee Giles Turrell.
Other news stories from 11/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
